Does vaginal dryness after menopause reflect reduced estrogen effect in urogenital tissues?

The transition to menopause and the accompanying decline in systemic and local estradiol levels directly alter the structure and microenvironment of the urogenital tract.

Clinical and physiological evidence

• Epithelial atrophy: The loss of estrogen-receptor-alpha (ESR1) signaling halts cellular renewal, leading to a marked thinning of the stratified squamous vaginal epithelium. This is cytologically characterized by a shift in the vaginal maturation index toward immature parabasal cells and a loss of superficial and intermediate squamous cells.
• Loss of tissue integrity: Thinning compromises mucosal barrier function, reducing the tissue's structural integrity, elasticity, and natural moisture-retention capabilities.

Mechanistic pathways of urogenital aging

• Vascular impairment: Estrogen withdrawal decreases local genital vascularization and mucosal blood flow. This circulatory decline directly limits the plasma transudation process that generates basal moisture, resulting in severe dryness.
• Microbiome and pH disruption: The loss of mature superficial cells reduces the glycogen content in the vaginal epithelium. This depletes protective Lactobacillus populations that rely on glycogen as a metabolic substrate, reducing lactic acid production and causing vaginal pH to rise and become alkaline (often >5).
• Extracellular matrix degeneration: Estrogen depletion leads to a decline in submucosal collagen, elastic fibers, and key water-binding extracellular matrix molecules like hyaluronic acid, impairing overall tissue turgor.

Bottom line

• Postmenopausal vaginal dryness is directly caused by estrogen depletion, which drives vaginal epithelial atrophy, reduces vascular transudation, and disrupts the protective, acidic vaginal microbiome.